Previous close | 551.00 |
Open | 439.56 |
Bid | 547.00 |
Ask | 556.00 |
Strike | 210.00 |
Expiry date | 2025-01-17 |
Day's range | 551.00 - 551.00 |
Contract range | N/A |
Volume | |
Open interest | 11 |
Novo Nordisk CEO Lars Jørgensen tells Yahoo Finance the company is confident about a robust GLP-1 sales year despite missing Wall Street estimates.
Online pharmacies and slimming clinics in Britain are reducing prices for Novo Nordisk A/S’s (NYSE:NVO) Wegovy and Eli Lilly And Co (NYSE:LLY) Mounjaro as initial supply shortages ease, a move driven by growing competition among retailers. The reduced prices at retailers like Simple Online Pharmacy, Mayfair Weight Loss Clinic, and London Slimming Clinic reflect the increasing demand for these weight-loss drugs. Simple Online Pharmacy, for instance, slashed the price of Mounjaro starter doses fro
(Bloomberg) -- Amgen Inc.’s shares soared in late trading after its chief executive officer said he was “very encouraged” by early results from a study of the company’s experimental obesity drug, MariTide. Most Read from BloombergSaudi Arabia Steps Up Arrests Of Those Attacking Israel OnlineTurkey Confirms All Trade Halt With Israel Over War in GazaHuawei Secretly Backs US Research, Awarding Millions in PrizesBiden Calls Ally Japan ‘Xenophobic’ Along With China, RussiaIn Jamie Dimon's America, t